Safety profile of herbal medicines submitted for marketing authorization in Tanzania: a cross-sectional retrospective study

ConclusionAnalysis of the herbal medicine dossiers submitted showed major deficiencies of safety data to support MA. Manufactures need to provide evidence to support the safety of their products for evidence-based regulatory decisions and to avoid multiple reviews of the applications.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research